FDA approves first-ever eye drop that corrects age-related vision loss
By
Alicia Lasek
Nov 02, 2021
The new drug, Vuity, adjusts pupil size and corrects near vision without affecting distance vision, drugmaker Allergan says.
Medical experts devise list of low-value drugs, prescribing practices
By
Caroline Szachnowski
Feb 22, 2022
Researchers have proposed a new metric for identifying low-value medication prescribing in older adults, according to a recent article in JAMA Network Open.
The McKnight’s Tech Awards are back! Recognize an innovation that has changed your game
By
James M. Berklan
May 05, 2021
The deadline is May 25 to highlight a technological innovation — simple or advanced — and show how it has improved care and/or operations in your organization.
On eve of Alzheimer’s drug decision, Congress critiques FDA for Aduhelm review failures
By
Alicia Lasek
Jan 03, 2023
An “atypical review process and corporate greed” factored into the FDA’s approval of Alzheimer’s drug Aduhelm in 2021, congressional investigators say. They recommend sticking to protocol...
FDA OKs new insulin biosimilar for type 2 diabetes
By
Alicia Lasek
Jul 30, 2021
Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.
Older adults who have received J&J need not be concerned: expert
By
Amy Novotney
Apr 20, 2021
Joshua Sharfstein, M.D., vice dean for public health practice and community engagement at Johns Hopkins University, has a message for older adults who have received the Johnson & Johnson COVID-19 vaccine:...
Hot water therapy boosts function in those with peripheral arterial disease
By
Alicia Lasek
Jun 12, 2019
Hot water therapy works just as well as supervised exercise to improve blood flow and functional walking ability in those with peripheral arterial disease, say New Zealand researchers.
To reach unvaccinated, U.S. secures 3.2M doses of Novavax vaccine
By
Liza Berger
Jul 12, 2022
Pending authorization by the Food and Drug Administration, the federal government has secured 3.2 million cases of Novavax’s COVID-19 vaccine.
OIG: Older Medicare recipients often harmed during hospital stays
May 13, 2022
Fully 25% of older American Medicare beneficiaries are at high risk of being harmed during acute care stays, according to the HHS Office of the Inspector General.
FDA: First-of-its-kind diagnostic test for Alzheimer’s gets green light
By
Alicia Lasek (f3)
May 06, 2022
The same-day test provides the same information as standard PET scans when diagnosing Alzheimer’s, the agency said.